For the fourth consecutive year, INOVOTION will be attending this major American convention.

This year, more than 15,900 attendees will come at the BIO convention with over 1,800 exhibitors. The exhibition will provide unparalleled access to KOLs, global biotech and pharma leaders, and industry and tech transfer organizations. This is a great opportunity to form strong partnerships and invest in innovative companies

INOVOTION’s technology is based on the chicken embryo in vivo model. The benefits of the model for in vivo studies are numerous and is a great solution to reduce the cost of your assays. If you are interested in learning more about our ingenious technology , come meet with Philippe Fornies, Business Development Director, and Jean Viallet, CEO & CSO on June 3-6!

For more information, feel free to contact us at: contact@inovotion.com.